SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
View ORCID ProfileMichael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, Keirstinne Turcios, Owen Janson, Sadie E. Munter, Cassandra Thanh, Christopher C. Nixon, Rebecca Hoh, Viva Tai, Emily A. Fehrman, Yanel Hernandez, Matthew A. Spinelli, Monica Gandhi, Mary-Ann Palafox, Ana Vallari, Mary A. Rodgers, John Prostko, John Hackett Jr., Lan Trinh, Terri Wrin, Christos J. Petroplolous, Charles Y. Chiu, Philip J. Norris, Clara DiGermanio, Mars Stone, Michael P. Busch, Susanna K. Elledge, Xin X. Zhou, James A. Wells, Albert Shu, Theodore W. Kurtz, John E. Pak, Wesley Wu, Peter D. Burbelo, Jeffrey I. Cohen, Rachel L. Rutishauser, Jeffrey N. Martin, View ORCID ProfileSteven G. Deeks, Timothy J. Henrich, Isabel Rodriguez-Barraquer, Bryan Greenhouse
doi: https://doi.org/10.1101/2021.03.03.21251639
Michael J. Peluso
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Saki Takahashi
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Jill Hakim
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
J. Daniel Kelly
2Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
Leonel Torres
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
3Division of Experimental Medicine, University of California, San Francisco, USA
Nikita S. Iyer
3Division of Experimental Medicine, University of California, San Francisco, USA
Keirstinne Turcios
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Owen Janson
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Sadie E. Munter
3Division of Experimental Medicine, University of California, San Francisco, USA
Cassandra Thanh
3Division of Experimental Medicine, University of California, San Francisco, USA
Christopher C. Nixon
3Division of Experimental Medicine, University of California, San Francisco, USA
Rebecca Hoh
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Viva Tai
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Emily A. Fehrman
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Yanel Hernandez
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Matthew A. Spinelli
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Monica Gandhi
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Mary-Ann Palafox
4Abbott Laboratories, Abbott Park, IL, USA
Ana Vallari
4Abbott Laboratories, Abbott Park, IL, USA
Mary A. Rodgers
4Abbott Laboratories, Abbott Park, IL, USA
John Prostko
4Abbott Laboratories, Abbott Park, IL, USA
John Hackett Jr.
4Abbott Laboratories, Abbott Park, IL, USA
Lan Trinh
5Monogram Biosciences, Inc., South San Francisco, CA, USA
Terri Wrin
5Monogram Biosciences, Inc., South San Francisco, CA, USA
Christos J. Petroplolous
5Monogram Biosciences, Inc., South San Francisco, CA, USA
Charles Y. Chiu
6Department of Laboratory Medicine, University of California, San Francisco, USA
7Division of Infectious Diseases, University of California, San Francisco, USA
8UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, USA
Philip J. Norris
9Vitalant Research Institute, San Francisco, CA, USA
Clara DiGermanio
9Vitalant Research Institute, San Francisco, CA, USA
Mars Stone
9Vitalant Research Institute, San Francisco, CA, USA
Michael P. Busch
6Department of Laboratory Medicine, University of California, San Francisco, USA
9Vitalant Research Institute, San Francisco, CA, USA
Susanna K. Elledge
10Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
Xin X. Zhou
10Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
James A. Wells
10Department of Pharmaceutical Chemistry, University of California, San Francisco, USA
11Department of Cellular & Molecular Pharmacology, University of California, San Francisco, USA
Albert Shu
6Department of Laboratory Medicine, University of California, San Francisco, USA
Theodore W. Kurtz
6Department of Laboratory Medicine, University of California, San Francisco, USA
John E. Pak
12Chan Zuckerberg Biohub, San Francisco, USA
Wesley Wu
12Chan Zuckerberg Biohub, San Francisco, USA
Peter D. Burbelo
13National Institute of Dental Research, National Institutes of Health, Bethesda, USA
Jeffrey I. Cohen
14Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
Rachel L. Rutishauser
3Division of Experimental Medicine, University of California, San Francisco, USA
Jeffrey N. Martin
2Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
Steven G. Deeks
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Timothy J. Henrich
3Division of Experimental Medicine, University of California, San Francisco, USA
Isabel Rodriguez-Barraquer
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
Bryan Greenhouse
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
- Supplemental Figure 1[supplements/251639_file08.pdf]
- Supplemental Figure 2[supplements/251639_file09.pdf]
- Supplemental Figure 3A[supplements/251639_file10.pdf]
- Supplemental Figure 3B[supplements/251639_file11.pdf]
- Supplemental Figure 3C[supplements/251639_file12.pdf]
- Supplemental Figure 3D[supplements/251639_file13.pdf]
- Supplemental Figure 4[supplements/251639_file14.pdf]
- Supplemental Figure 5[supplements/251639_file15.pdf]
- Supplemental Figure 6[supplements/251639_file16.pdf]
- Supplemental Figure 7[supplements/251639_file17.pdf]
- Supplemental Table 1[supplements/251639_file18.xlsx]
- Supplemental Table 2[supplements/251639_file19.xlsx]
- Supplemental Table 3[supplements/251639_file20.xlsx]
- Supplemental Table 4[supplements/251639_file21.xlsx]
- Supplemental Table 5[supplements/251639_file22.xlsx]
- Supplemental Table 6[supplements/251639_file23.xlsx]
- Supplemental Table 7[supplements/251639_file24.xlsx]
- Supplemental Table 8[supplements/251639_file25.xlsx]
- Supplemental Table 9[supplements/251639_file26.xlsx]
- Supplemental Table 10[supplements/251639_file27.xlsx]
- Supplemental Table 11[supplements/251639_file28.xlsx]
Posted March 05, 2021.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, Keirstinne Turcios, Owen Janson, Sadie E. Munter, Cassandra Thanh, Christopher C. Nixon, Rebecca Hoh, Viva Tai, Emily A. Fehrman, Yanel Hernandez, Matthew A. Spinelli, Monica Gandhi, Mary-Ann Palafox, Ana Vallari, Mary A. Rodgers, John Prostko, John Hackett Jr., Lan Trinh, Terri Wrin, Christos J. Petroplolous, Charles Y. Chiu, Philip J. Norris, Clara DiGermanio, Mars Stone, Michael P. Busch, Susanna K. Elledge, Xin X. Zhou, James A. Wells, Albert Shu, Theodore W. Kurtz, John E. Pak, Wesley Wu, Peter D. Burbelo, Jeffrey I. Cohen, Rachel L. Rutishauser, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, Isabel Rodriguez-Barraquer, Bryan Greenhouse
medRxiv 2021.03.03.21251639; doi: https://doi.org/10.1101/2021.03.03.21251639
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Michael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, Keirstinne Turcios, Owen Janson, Sadie E. Munter, Cassandra Thanh, Christopher C. Nixon, Rebecca Hoh, Viva Tai, Emily A. Fehrman, Yanel Hernandez, Matthew A. Spinelli, Monica Gandhi, Mary-Ann Palafox, Ana Vallari, Mary A. Rodgers, John Prostko, John Hackett Jr., Lan Trinh, Terri Wrin, Christos J. Petroplolous, Charles Y. Chiu, Philip J. Norris, Clara DiGermanio, Mars Stone, Michael P. Busch, Susanna K. Elledge, Xin X. Zhou, James A. Wells, Albert Shu, Theodore W. Kurtz, John E. Pak, Wesley Wu, Peter D. Burbelo, Jeffrey I. Cohen, Rachel L. Rutishauser, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, Isabel Rodriguez-Barraquer, Bryan Greenhouse
medRxiv 2021.03.03.21251639; doi: https://doi.org/10.1101/2021.03.03.21251639
Subject Area
Subject Areas
- Addiction Medicine (342)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2625)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12176)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4064)
- Geriatric Medicine (385)
- Health Economics (676)
- Health Informatics (2625)
- Health Policy (997)
- Hematology (360)
- HIV/AIDS (845)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (430)
- Neurology (3834)
- Nursing (209)
- Nutrition (570)
- Oncology (2008)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6499)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)